The global Non-Invasive Prenatal Testing Market is anticipated to grow at 12.35% CAGR during the forecast period. Factors attributing to the growth of the Non-Invasive Prenatal Testing Market include the rising prominence of SSIs, rising number of surgical procedures, technological development of innovating new products, significant increase in the occurrence of complications from HAIs, and rising geriatric population. Nevertheless, the growing initiatives by government and rising number of collaborations by key industry players will create opportunities for growth of the Non-Invasive Prenatal Testing Market.
3M is on the mission to protect patients from preventable surgical site infections (SSIs) as they believe that up to 5% of patients undergoing surgery may have negative consequences of an SSI, as patients might have an increased length of stay in hospital that can impact the quality of life. So they are committed to using their best practices and evidence-based solutions to reduce the risk of SSIs in the facility
The COVID-19 outbreak has had a negative impact on Non-Invasive Prenatal Testing Market owing to decrease in funding of R&D activities associated with surgical site infection control agents and decrease in number of elective surgeries will adversely affect the market.
Browse 60 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " Non-Invasive Prenatal Testing Market by Product (Instruments and Consumables), by Method (Cell- Free DNA in Maternal Plasma Tests, Ultrasound Detection, Fetal Cell in Maternal Blood Tests, and Biochemical Screening Tests), by Application (Microdeletion Syndrome, Trisomy and Others), and by End User (Hospitals and Diagnostic Laboratories), and Region - Global Forecast to 2030"
By product, antibiotic prophylaxis contributes to the largest share in the Non-Invasive Prenatal Testing Market in 2022.
Based on product, the Non-Invasive Prenatal Testing Market is segmented into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products and others. The antibiotic prophylaxis dominate the market owing to the increased cost of antibiotics, acceptance of antibiotics as most established preventive method for surgical site infections and patient friendly dosage forms like tablets, capsules, etc.
Global Non-Invasive Prenatal Testing Market Segmentation Analysis
Segment |
Categorization |
Leading Category |
Product |
Instruments and Consumables |
Antibiotic Prophylaxis (Largest) Antiseptics and Disinfectants (Fastest) |
Method |
Cell- Free DNA in Maternal Plasma Tests, Ultrasound Detection, Fetal Cell in Maternal Blood Tests, and Biochemical Screening Tests |
Intraoperative (Largest)
|
Application |
Microdeletion Syndrome, Trisomy and Others |
|
End User |
Hospitals and Diagnostic Laboratories |
Ambulatory Surgery Centers (Fastest) |
Region |
North America, Europe, Asia-Pacific, and Rest of the World |
North America (Largest) Asia-Pacific (Fastest) |
Discover More About This Report, Download A Free Sample Copy of Global Non-Invasive Prenatal Testing Market
“Asia-Pacific is anticipated to be the fastest growing region in the Non-Invasive Prenatal Testing Market during 2023-2030.”
Asia-Pacific is expected to be the fastest-growing region in the Non-Invasive Prenatal Testing Market owing to increasing patient pool, increased awareness by government organizations, abd rising prominence of surgical site infections.
Some of the major players in the Non-Invasive Prenatal Testing Market include 3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc.
Scope of the Report
Report Metric |
Details |
Market Size Available for the Years in the Study |
2018–2030 |
Historical Period |
2018–2022 |
Base Year |
2022 |
Forecast Period |
2023–2030 |
Segments Covered in the Study |
Product, Method, Application, End User, and Region |
Geographies Covered in the Study |
North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia), Asia-Pacific (China, Japan, India, South Korea), and Rest of the World (Brazil, Saudi Arabia, South Africa, U.A.E.) |
Companies Covered in the Study |
3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc |
Global Non-Invasive Prenatal Testing Market Coverage
Product Insight and Forecast 2018-2030
Method Insight and Forecast 2018-2030
Application Insight and Forecast 2018-2030
End User Insight and Forecast 2018-2030
Geographical Segmentation
Non-Invasive Prenatal Testing Market by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)